Baxter International Inc (NYSE:BAX)
$ 33.9 -0.1 (-0.29%) Market Cap: 17.27 Bil Enterprise Value: 28.42 Bil PE Ratio: 6.52 PB Ratio: 2.11 GF Score: 79/100

Baxter International Inc at UBS Global Healthcare Conference Transcript

May 20, 2019 / 05:00PM GMT
Release Date Price: $75.32 (-0.87%)
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Okay. Thanks for joining us for our first session here after lunch. I am Matt Taylor, the U.S. medical supplies and devices analyst here at UBS. And I'm joined by management from Baxter, including Jay Saccaro, who's the EVP and Chief Financial Officer; and Clare Trachtman, VP of Investor Relations.

So I just want to start out here and give Jay a chance to make some opening comments about Baxter. And then we'll move through a fireside chat Q&A format. And just want to remind everyone that we're going to do some interactive questions. So you haven't downloaded the app, it's a UBS conference app, where you can look at the Q&A portion of each session. And I'll ask questions throughout the fireside chat.

But first, Jay, why don't you get started and make some opening comments. And then we'll get right into it.

James K. Saccaro
Baxter International Inc. - Executive VP & CFO

Great, Matt. Thanks for inviting us. Is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot